Quetiapine is an atypical antipsychotic drug used for treatments of patients with schizophrenia. Although hepatotoxic effects related to quetiapine treatment were reported in a few studies, potential hepatotoxicity of this drug was not identified. Therefore, it was aimed to evaluate the possible hepatotoxic effects of quetiapine by oral administration of this drug at 10 and 20 mg/kg doses to rats for 30 days in our study. For this purpose, plasma aspartate aminotransferase, alanine aminotransferase, total bilirubin and direct bilirubin levels as markers of hepatotoxicity were determined and histopathological examination was performed in liver tissues. Additionally, we evaluated GSH levels in liver tissues. According to our results, serum aspartate aminotransferase and alanine aminotransferase levels were significantly increased in quetiapine-administered groups, whereas total and direct bilirubin levels were significantly increased in the high dose group. Histopathological investigation of liver tissue indicated that necrotic regions were present in 10 mg/kg quetiapine-administered group whereas prevalent necrotic regions accompanying sinusoidal dilatation were observed in 20 mg/kg quetiapine-administered group. Otherwise, there is not any significant difference among groups in terms of GSH levels. According to these results, we concluded that quetiapine treatment induced hepatotoxic effects in rats, dose-dependently.